New & Noteworthy

September 2022

Triamcinolone Acetonide Injectable Suspension, USP

Long Grove Pharmaceuticals

Long Grove Pharmaceuticals launches triamcinolone acetonide injectable suspension, USP, which is indicated for multiple conditions including the treatment of various types of arthritis. The FDA-approved generic is an AB-rated generic for Kenalog-40, is TAA compliant, and made in the European Union. It is available in single and multiple vial presentations and does not contain natural rubber latex. This launch is the first in a series of releases planned for the coming year. Long Grove Pharmaceuticals is a generics manufacturer focusing on complex generics, including injectables and topical products.

Request More Information

Current Issue